Close

Press Releases

Nexavar Continues to Dominate Advanced Liver Cancer Therapy, as Other Late Stage Trials Fail

Hepatocellular carcinoma (HCC), the most common form of liver cancer, carries a deadly reputation, and patients face shrinking hopes of new treatment options as drug trials hit problems, according to a new report by healthcare experts. ...

LI-COR Biosciences Transforms Western Blotting with Innovative New System

Today, LI-CORยฎ Biosciences continues to demonstrate its position as a leader in laboratory instrument systems as it announces the launch of the C-DiGitโ„ข Blot Scanner. A technological advancement for biotechnology laboratories, C-DiGit Blot Scanner is...

Novasep launches the Sius(TM) single-use TFF skid, completing the first 100 per cent single-use TFF solution for pre-clinical to clinical cGMP biomanufacturing

Novasep, a leading supplier of purification solutions to the life sciences industries, today announces the launch of its Sius(TM) single-use tangential flow filtration (TFF) skid. The TFF skid completes the Novasep proprietary, single-use TFF solution for pre-clinical to...

Clasado announces positive results of clinical study of Bimuno(R) for Metabolic Syndrome

Clasado, the manufacturers and suppliers of Bimuno(R), a unique trans-galactooligosaccharide prebiotic, today announces the results of a clinical study on the use of the Bimuno (B-GOS) to alter bacteria in the human gastrointestinal tract as a candidate to...

e-Therapeutics to Raise GBP 40 Million to Advance Lead Cancer Drug and Exploit Network Pharmacology Platform

Drug discovery and development company e-Therapeutics plc proposes to raise GBP 40 million (approximately GBP 39million net) through an issue of new ordinary shares to existing and new institutional investors. The new shares will be...

Labeling Considerations in the European Union and its Impact on Global Labeling Compliance

Designing a product label is a long and complex process, from the amount of time that is needed, to creating a label that is compliant with the current FDA regulations. Pharmaceutical companies are constantly managing...

Alpha Szenszor Inc. and Technion Announce Joint Venture in Lung Cancer Diagnostics

Alpha Szenszor Inc., a leading provider of carbon nanotube based sensors and the Technion -Israel Institute of Technology have announced a joint venture for the commercialization of advanced lung cancer diagnostics based on Volatile Organic Compound (VOC) detection...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป